Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | GSK3A | P49840 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25332258 | 0.77 | KDM4E (0.42) | KDM4EGAACYP2C19CYP2C9CYP1A2 | |
| SCHEMBL24076898 | 0.77 | GAA (0.49) | KDM4EGAACYP2C19CYP2C9CYP1A2 | |
| SCHEMBL29899415 | 0.76 | ALDH1A1 (0.46) | KDM4EGAACYP2C19CYP2C9MAPK1 | |
| SCHEMBL25746202 | 0.74 | GAA (0.51) | KDM4EGAACYP2C19CYP2C9CYP1A2 | |
| SCHEMBL24077023 | 0.72 | MAPK8 (0.49) | KDM4EGAACYP2C19CYP2C9CYP1A2 | |
| SCHEMBL23792573 | 0.72 | MAPK1 (0.40) | KDM4EGAACYP2C19CYP2C9L3MBTL1 | |
| SCHEMBL29899373 | 0.72 | ALDH1A1 (0.44) | KDM4EGAACYP2C19CYP2C9MAPK1 | |
| SCHEMBL14488238 | 0.71 | MAPK1 (0.40) | KDM4ECYP2C19MAPK1GSK3AGSK3B | |
| SCHEMBL23793626 | 0.71 | CYP2C19 (0.40) | KDM4EGAACYP2C19CYP2C9MAPK1 | |
| SCHEMBL25333499 | 0.71 | CYP2C19 (0.41) | KDM4EGAACYP2C19CYP2C9CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240109905-A1 | 4-ALKOXY-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3 | JANSSEN PHARMACEUTICA NV (BE) | 2024-04-04 | — | — | US | disclosed |
| EP-4301753-A1 | 4-ALKOXY-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3 | Janssen Pharmaceutica NV (BE) | 2024-01-10 | — | — | EP | disclosed |
| WO-2022184842-A1 | 4-ALKOXY-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3 | JANSSEN PHARMACEUTICA NV (BE) | 2022-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109905-A1 | 4-ALKOXY-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3 | NLRP3, NLRP1, PYCARD | KDM4E 2109/4885GAA 3344/4885CYP2C19 1954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.